These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32798842)

  • 41. Early detection of Parkinson's disease through patient questionnaire and predictive modelling.
    Prashanth R; Dutta Roy S
    Int J Med Inform; 2018 Nov; 119():75-87. PubMed ID: 30342689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.
    Park JW; Kwon DY; Choi JH; Park MH; Yoon HK
    Parkinsonism Relat Disord; 2018 Jan; 46():69-73. PubMed ID: 29233469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying clinical features and blood biomarkers associated with mild cognitive impairment in Parkinson disease using machine learning.
    Deng X; Ning Y; Saffari SE; Xiao B; Niu C; Ng SYE; Chia N; Choi X; Heng DL; Tan YJ; Ng E; Xu Z; Tay KY; Au WL; Ng A; Tan EK; Liu N; Tan LCS
    Eur J Neurol; 2023 Jun; 30(6):1658-1666. PubMed ID: 36912424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mild cognitive impairment in Parkinson's disease.
    Martinez-Horta S; Kulisevsky J
    J Neural Transm (Vienna); 2019 Jul; 126(7):897-904. PubMed ID: 30963293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?
    Loued-Khenissi L; Preuschoff K
    Curr Opin Neurol; 2015 Aug; 28(4):344-50. PubMed ID: 26110801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Prague Stroop Test: Normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson's disease.
    Bezdicek O; Lukavsky J; Stepankova H; Nikolai T; Axelrod BN; Michalec J; Růžička E; Kopecek M
    J Clin Exp Neuropsychol; 2015; 37(8):794-807. PubMed ID: 26313510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mild cognitive impairment in Parkinson's disease: Characterization and impact on quality of life according to subtype.
    Vasconcellos LFR; Pereira JS; Charchat-Fichman H; Greca D; Cruz M; Blum AL; Spitz M
    Geriatr Gerontol Int; 2019 Jun; 19(6):497-502. PubMed ID: 30912284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.
    Bezdicek O; Michalec J; Nikolai T; Havránková P; Roth J; Jech R; Růžička E
    Dement Geriatr Cogn Disord; 2015; 39(5-6):303-11. PubMed ID: 25792240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of machine learning in diagnosing cognitive impairment in patients with Parkinson's disease: a systematic review and meta-analysis.
    Sun M; Yan T; Liu R; Zhao X; Zhou X; Ma Y; Jia J
    Ann Palliat Med; 2022 Dec; 11(12):3775-3784. PubMed ID: 36636002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mild cognitive impairment, dementia, and cognitive dysfunction screening using machine learning.
    Yim D; Yeo TY; Park MH
    J Int Med Res; 2020 Jul; 48(7):300060520936881. PubMed ID: 32644870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cognitive impairment in Parkinson's disease].
    Tachibana H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis.
    Saredakis D; Collins-Praino LE; Gutteridge DS; Stephan BCM; Keage HAD
    Parkinsonism Relat Disord; 2019 Aug; 65():20-31. PubMed ID: 31109727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gradient boosting for Parkinson's disease diagnosis from voice recordings.
    Karabayir I; Goldman SM; Pappu S; Akbilgic O
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):228. PubMed ID: 32933493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.